BLCOBausch + Lomb Corp.
$14.79
$0.21
(1.37%)
Closed $15.08
$0.29
(1.92%)
After Hours
EarningsJul 29
Mkt Cap$5.38B
Vol276,316.00
Fundamentals
Mkt Cap
$5.38B
Volume
-
52W High
$18.92
52W Low
$11.44
PE Ratio
-24.41
Avg. Volume
472,055.36
EPS (Annual)
-$1.02
Rev/Employee
$392,384.62
Earnings
Jul 29
Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Bausch + Lomb Launches Blink Triple Care Preservative Free Lubricant Eye Drops in the United States
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Triple Care Preservative Free eye drops, which provide instant, long-lasting relief for dry eyes without the use of...
Business Wire
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical Officer and Head of Research and Development Yehia Hashad, MD, will participate in a fireside...
Business Wire
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2026 annual meeting of shareholders (the Annual Meeting) held on May 20, 2026. The detailed...
Business Wire
Bausch + Lomb Launches PreserVision AREDS3 Eye Vitamins in the United States
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of PreserVision AREDS3 eye vitamins, which combine the clinically proven AREDS2 nutrients recommended by the NEI to help reduce the...
Business Wire
Bausch + Lomb Launches Bi-Blade+ Dual-Port Vitrectomy Cutter in Europe
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the European launch of the Bi-Blade+ advanced...
Business Wire
Bausch + Lomb Announces Second R&D Teach-in Webinar
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the second event in its R&D Teach-in webinar...
Business Wire
Bausch + Lomb (NYSE:BLCO) Issues Earnings Results
Bausch + Lomb (NYSE:BLCO - Get Free Report) released its earnings results on Wednesday. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.06 by $0.02. Bausch + Lomb had a negative net margin of 7.06% and a positive return on equity of 2.77%. The company had...
MarketBeat
AI could take 'years' off the drug development process, says Bausch + Lomb CEO Brent Saunders
AI could take 'years' off the drug development process, says Bausch + Lomb CEO Brent Saunders...
CNBC Television-YouTube
Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript
@media (max-width: 768px) {
.image-container {
width: 100% !important;
float: none !important;
margin: 0 0 1rem 0 !important;
}
}
Image source: The Mo...
Nasdaq News: Markets
<
1
2
...
>
Advertisement|Remove ads.
Latest BLCO News
ViewAlignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?
Zacks
Bausch + Lomb Launches Blink Triple Care Preservative Free Lubricant Eye Drops in the United States
Business Wire
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Business Wire
Advertisement|Remove ads.